Not Medicare Enrolled

Dr. Vernon Johnson, M.D.

Child & Adolescent Psychiatry Physician · Sherman, TX
Low-engagement
302 E BROCKETT ST, Sherman, TX 75090
9038931400
In practice since 2007 (19 years)
NPI: 1639228992 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Johnson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Johnson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Johnson

Dr. Vernon Johnson is a child & adolescent psychiatry physician in Sherman, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Johnson received a total of $4,482 from 38 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Johnson is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $4,482 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,482
Total received (2018-2024)
Avg $640/year across 7 years
Top 12% in TX for child & adolescent psychiatry physician
38
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,482 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$607
2023
$439
2022
$38
2021
$603
2020
$628
2019
$1,440
2018
$728

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$785
Sunovion Pharmaceuticals Inc.
$516
Ironshore Pharmaceuticals Inc.
$364
Allergan, Inc.
$252
Allergan Inc.
$218
ITI, Inc.
$215
Janssen Pharmaceuticals, Inc
$203
Tris Pharma Inc
$188
Shire North American Group Inc
$184
Supernus Pharmaceuticals, Inc.
$171
AbbVie Inc.
$125
Avanir Pharmaceuticals, Inc.
$109
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$103
Teva Pharmaceuticals USA, Inc.
$93
Eisai Inc.
$91
Noven Therapeutics, LLC
$75
Corium, LLC
$74
Adlon Therapeutics L.P.
$74
Lundbeck LLC
$67
Neurocrine Biosciences, Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$55
Almatica Pharma LLC
$54
Vertical Pharmaceuticals, LLC
$51
ARBOR PHARMACEUTICALS, INC.
$41
Neos Therapeutics, LP
$38
GE HEALTHCARE
$36
Axsome Therapeutics, Inc.
$33
Tempus AI, Inc
$26
Jazz Pharmaceuticals Inc.
$23
Neuronetics, Inc.
$19
ABBVIE INC.
$19
E.R. Squibb & Sons, L.L.C.
$17
Indivior Inc.
$17
Alkermes, Inc.
$17
Bausch Health US, LLC
$17
JAZZ PHARMACEUTICALS INC.
$15
OWP Pharmaceuticals, Inc.
$15
LivaNova USA, Inc.
$14
Top 3 companies account for 37.1% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · Adzenys XR-ODT · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · Dyanavel XR · Evekeo · Evekeo ODT · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · QELBREE · Qelbree · Quillichew ER · Quillivant · RELEXXII · REXULTI · SECUADO · SPRAVATO · SUBLOCADE · SUNOSI · Subvenite · TRINTELLIX · UBRELVY · VIIBRYD · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VRAYLAR · VYVANSE · Vyvanse · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a child & adolescent psychiatry physician in Sherman?
Compare child & adolescent psychiatry physicians in the Sherman area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & Adolescent Psychiatry Physicians within 10 mi
1
Per 100K population
0.7
County median income
$70,455
Nearest hospital
BAYLOR SCOTT AND WHITE SURGICAL HOSPITAL AT SHERMA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Johnson is a child & adolescent psychiatry physician, and high industry engagement (low-engagement, top 12%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Johnson receive payments from pharmaceutical companies?
Yes. Dr. Johnson received a total of $4,482 from 38 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Johnson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →